Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 544009 | NSE: BLUEJET

429.00
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  425.90
  •  439.50
  •  420.20
  •  423.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  259304
  •  1118.04
  •  579.40
  •  319.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,256.98
  • 54.56
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,171.00
  • 0.19%
  • 9.91

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 86.00%
  • 3.10%
  • 5.90%
  • FII
  • DII
  • Others
  • 2.18%
  • 0.99%
  • 1.83%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 1.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -1.66

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -3.39

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 21
Net Sales
-
498.93
Net Sales Growth
-
 
Cost Of Goods Sold
-
169.45
Gross Profit
-
329.48
GP Margin
-
66.04%
Total Expenditure
-
292.88
Power & Fuel Cost
-
19.91
% Of Sales
-
3.99%
Employee Cost
-
28.95
% Of Sales
-
5.80%
Manufacturing Exp.
-
53.37
% Of Sales
-
10.70%
General & Admin Exp.
-
8.11
% Of Sales
-
1.63%
Selling & Distn. Exp.
-
4.20
% Of Sales
-
0.84%
Miscellaneous Exp.
-
8.87
% Of Sales
-
1.78%
EBITDA
-
206.05
EBITDA Margin
-
41.30%
Other Income
-
8.88
Interest
-
5.31
Depreciation
-
19.66
PBT
-
189.96
Tax
-
48.87
Tax Rate
-
26.47%
PAT
-
138.42
PAT before Minority Interest
-
135.79
Minority Interest
-
2.63
PAT Margin
-
27.74%
PAT Growth
-
 
EPS
-
7.98

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Shareholder's Funds
339.82
Share Capital
9.91
Total Reserves
329.91
Non-Current Liabilities
33.35
Secured Loans
28.67
Unsecured Loans
0.00
Long Term Provisions
3.29
Current Liabilities
220.04
Trade Payables
59.53
Other Current Liabilities
46.11
Short Term Borrowings
7.13
Short Term Provisions
107.27
Total Liabilities
593.21
Net Block
138.92
Gross Block
176.03
Accumulated Depreciation
37.11
Non Current Assets
146.24
Capital Work in Progress
2.58
Non Current Investment
0.00
Long Term Loans & Adv.
4.66
Other Non Current Assets
0.08
Current Assets
446.97
Current Investments
36.84
Inventories
117.72
Sundry Debtors
144.00
Cash & Bank
70.45
Other Current Assets
77.97
Short Term Loans & Adv.
73.77
Net Current Assets
226.93
Total Assets
593.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Cash From Operating Activity
129.28
PBT
184.66
Adjustment
17.55
Changes in Working Capital
-72.73
Cash after chg. in Working capital
129.47
Interest Paid
0.00
Tax Paid
-0.20
Other Direct Exp. Paid
0.00
Extra & Other Items
0.00
Cash From Investing Activity
-50.73
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
-27.50
Net Cash Inflow / Outflow
51.05
Opening Cash & Equivalents
10.07
Closing Cash & Equivalent
61.13

Financial Ratios

Standalone /

Consolidated
Description
Mar 21
Book Value (Rs.)
19.59
ROA
26.50%
ROE
51.06%
ROCE
56.68%
Fixed Asset Turnover
3.31
Receivable days
96.02
Inventory Days
68.30
Payable days
120.13
Cash Conversion Cycle
44.18
Total Debt/Equity
0.15
Interest Cover
35.79

Annual Reports:

News Update:


  • Blue Jet Healthcare - Quarterly Results
    29th Oct 2024, 13:01 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.